Advertisement

Topics

Abeona Reports Third Quarter 2017 Financial Results and Recent Business Highlights

09:25 EST 15 Nov 2017 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
Investor Conference Call to be held Monday, November 20th at 10:00 am ET Global enrollment continues in ABO-102 trial for MPS IIIA Screening initiated in ABO-101 Phase 1/2 trial for MPS IIIB Pivotal Phase 3 planning underway for EB-101 progr...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Abeona Reports Third Quarter 2017 Financial Results and Recent Business Highlights"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...